291F Strayer, David S. - Thomas Jefferson University - Thomas Jefferson University
dss101

David S. Strayer, MD, PhD

Contact Dr. Strayer

1020 Locust Street
Jefferson Alumni Hall, Suite 471
Philadelphia, PA 19107

(215) 503-1087
(215) 503-1156 fax

Most Recent Peer-reviewed Publications

  1. Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection
  2. Ethanol stimulates angiogenesis via vascular endothelial growth factor and protects from ischemia and reperfusion injury
  3. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: Consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy
  4. Loss of HtrA2/Omi activity in non-neuronal tissues of adult mice causes premature aging
  5. HIV-1-associated neurocognitive disorder: Role of oxidative stress and protection by gene delivery of antioxidant enzymes
  6. Modulation of microglial reaction in brain injury by novel therapeutic tools based on gene therapy approaches
  7. HIV -1 GP120 induces blood -brain barrier abnormalities: Pathophysiology and therapeutic consequences
  8. Raphael Rubin, 1956-2011
  9. Ethanol protects from injury due to ischemia and reperfusion by increasing vascularity via vascular endothelial growth factor
  10. Gene delivery of antioxidant enzymes inhibits human immunodeficiency virus type 1 gp120-induced expression of caspases
  11. Blood-brain barrier abnormalities caused by HIV-1 gp120: Mechanistic and therapeutic implications
  12. HIV-1 Tat neurotoxicity: A model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes
  13. Intracisternal rSV40 administration provides effective pan-CNS transgene expression
  14. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy
  15. Perfluorochemical liquid-adenovirus suspensions enhance gene delivery to the distal lung
  16. Bone marrow-derived cells migrate to line the vessels of the CNS: Opportunities for gene delivery to CNS vasculature
  17. Lymphocyte adhesion to CCR5 ligands is reduced by anti-CCR5 gene delivery
  18. Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe
  19. Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage
  20. Gene transfer to the cerebellum
0